Should Bed Bath & Beyond Get More Credit for Q4?
Bed Bath & Beyond stock drooped after it released mixed fiscal fourth-quarter financial results.
Bed Bath & Beyond stock drooped after it released mixed fiscal fourth-quarter financial results.
Rite Aid released mixed fiscal fourth-quarter financial results before the markets opened on Thursday.
Wednesday was a relatively positive day for the broad U.S. markets. While the S&P 500 and Nasdaq made meaningful gains on Monday, while the Dow was more or less flat. Keep in mind that…
One research firm believes that Snap stock is vastly overvalued and that the growth outlook for Snapchat’s U.S. social usage is questionable.
Levi Strauss shares made a solid gain on Wednesday after the firm posted its fiscal first-quarter financial results.
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
The March 29 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with two major movers in the group.
The March 29 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The March 29 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
Tuesday was a down day for the broad U.S. markets. While the S&P 500 and Nasdaq were marginally positive on Monday, they gave back all their gains and then some in Tuesday’s session. Although…
IBM is as one of the three best-performing Dow Jones industrials so far in 2019, and it seems the bulls are calling for this stock to rise even higher.
Chimerix shares jumped sharply on Tuesday after the firm announced that it would be making changes to its executive team.
Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment of seizures associated with Dravet syndrome.
PhaseBio shares made a sizeble gain on Tuesday morning after the FDA provided a critical update for the firm.
Monday was a mixed day for the broad U.S. markets. The S&P 500 and Nasdaq were marginally positive on the day while the Dow lagged way behind. Although it was not a particularly busy…
Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA interference therapeutics for a broad range of diseases.
Coherus BioSciences shares jumped on Monday morning after the firm released updated sales for its first quarter.
24/7 Wall St. has put together a preview of Delta Air Lines, Well Fargo and some of the other major companies reporting their quarterly results this week.
Friday was a positive day for the broad U.S. markets. The S&P 500 and Nasdaq led the charge for the day while the DJIA was only marginally positive. Crude oil pushed even higher in…
Triumph Group investors seemed pleased on Friday after the firm announced that it is exploring strategic alternatives for its Aerospace Structures business.